Answers are grounded in this paper and cite their sources.
In a recent study, Rolf Müller and colleagues identified a novel myxobacterial family Pendulisporaceae, encompassing four new strains with biosynthetic gene clusters (BGCs) largely distinct from known families. These strains, sourced from 1980s soil samples, display unique genomic and chemical features, suggesting significant biotechnological and pharmaceutical potential. This study underscores the value of exploring underrepresented microbial taxa for novel natural products, highlighting the potential of the family Pendulisporaceae as a source of new antimicrobial and therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Shukla et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: